|
Treatment Algorithm for Homozygous or Compound Heterozygous DPYD Variant Allele Carriers With Low-Dose Capecitabine.
|
Henricks LM, Kienhuis E, de Man FM, van der Veldt AAM, Hamberg P, van Kuilenburg ABP, van Schaik RHN, Lunenburg CATC, Guchelaar HJ, Schellens JHM, Mathijssen RHJ
|
35172514
|
01-11-2017
|
06-05-2026
|
|
|
Traceability in laboratory medicine: a global driver for accurate results for patient care.
|
Beastall GH, Brouwer N, Quiroga S, Myers GL, prepared on behalf of the Joint Committee for Traceability in Laboratory Medicine
|
28593871
|
26-07-2017
|
16-04-2026
|
|
|
Food ingestion in an upright sitting position increases postprandial amino acid availability when compared with food ingestion in a lying down position.
|
Holwerda AM, Lenaerts K, Bierau J, Wodzig WKWH, van Loon LJC
|
28212491
|
01-07-2017
|
14-04-2026
|
|
|
Large Variation in Measured Cardiac Troponin T Concentrations after Standard Addition in Serum or Plasma of Different Individuals.
|
van der Linden N, Streng AS, Bekers O, Wodzig WKWH, Meex SJR, de Boer D
|
28536101
|
01-07-2017
|
14-04-2026
|
|
|
Letter regarding Zhao et al. entitled " DPYD gene polymorphisms are associated with risk and chemotherapy prognosis in pediatric patients with acute lymphoblastic leukemia".
|
Deenen MJ, Henricks LM, Sonke GS, Schellens JH, Meulendijks D
|
28618970
|
01-06-2017
|
06-05-2026
|
|
|
Pretreatment serum uracil concentration as a predictor of severe and fatal fluoropyrimidine-associated toxicity.
|
Meulendijks D, Henricks LM, Jacobs BAW, Aliev A, Deenen MJ, de Vries N, Rosing H, van Werkhoven E, de Boer A, Beijnen JH, Mandigers CMPW, Soesan M, Cats A, Schellens JHM
|
28427087
|
23-05-2017
|
06-05-2026
|
|
|
Identification and Characterization of Cardiac Troponin T Fragments in Serum of Patients Suffering from Acute Myocardial Infarction.
|
Streng AS, de Boer D, van Doorn WP, Bouwman FG, Mariman EC, Bekers O, van Dieijen-Visser MP, Wodzig WK
|
27940450
|
01-02-2017
|
14-04-2026
|
|
|
Cardiac troponin T degradation in serum is catalysed by human thrombin.
|
Streng AS, de Boer D, van Doorn WP, Kocken JM, Bekers O, Wodzig WK
|
27816455
|
02-12-2016
|
14-04-2026
|
|
|
Increasing Insulin Availability Does Not Augment Postprandial Muscle Protein Synthesis Rates in Healthy Young and Older Men.
|
Groen BB, Horstman AM, Hamer HM, de Haan M, van Kranenburg J, Bierau J, Poeze M, Wodzig WK, Rasmussen BB, van Loon LJ
|
27745529
|
01-11-2016
|
14-04-2026
|
|
|
Patients homozygous for DPYD c.1129-5923C>G/haplotype B3 have partial DPD deficiency and require a dose reduction when treated with fluoropyrimidines.
|
Meulendijks D, Henricks LM, van Kuilenburg AB, Jacobs BA, Aliev A, Rozeman L, Meijer J, Beijnen JH, de Graaf H, Cats A, Schellens JH
|
27544765
|
01-10-2016
|
06-05-2026
|
|
|
Development and validation of a rapid and sensitive UPLC-MS/MS method for determination of uracil and dihydrouracil in human plasma.
|
Jacobs BA, Rosing H, de Vries N, Meulendijks D, Henricks LM, Schellens JH, Beijnen JH
|
27179185
|
15-07-2016
|
06-05-2026
|
|
|
Physical Activity Performed in the Evening Increases the Overnight Muscle Protein Synthetic Response to Presleep Protein Ingestion in Older Men.
|
Holwerda AM, Kouw IW, Trommelen J, Halson SL, Wodzig WK, Verdijk LB, van Loon LJ
|
27281811
|
01-07-2016
|
14-04-2026
|
|
|
Rs895819 in MIR27A improves the predictive value of DPYD variants to identify patients at risk of severe fluoropyrimidine-associated toxicity.
|
Meulendijks D, Henricks LM, Amstutz U, Froehlich TK, Largiadèr CR, Beijnen JH, de Boer A, Deenen MJ, Cats A, Schellens JH
|
26804235
|
01-06-2016
|
06-05-2026
|
|
|
Development of a targeted selected ion monitoring assay for the elucidation of protease induced structural changes in cardiac troponin T.
|
Streng AS, de Boer D, Bouwman FG, Mariman EC, Scholten A, van Dieijen-Visser MP, Wodzig WK
|
26772903
|
16-03-2016
|
14-04-2026
|
|
|
Validation, optimisation, and application data in support of the development of a targeted selected ion monitoring assay for degraded cardiac troponin T.
|
Streng AS, de Boer D, Bouwman FG, Mariman EC, Scholten A, van Dieijen-Visser MP, Wodzig WK
|
26977445
|
03-03-2016
|
14-04-2026
|
|
|
Prospective DPYD genotyping to reduce the risk of fluoropyrimidine-induced severe toxicity: Ready for prime time.
|
Lunenburg CATC, Henricks LM, Guchelaar HJ, Swen JJ, Deenen MJ, Schellens JHM, Gelderblom H
|
26716401
|
01-02-2016
|
06-05-2026
|
|
|
Ascorbic acid serum levels are reduced in patients with hematological malignancies.
|
Huijskens MJ, Wodzig WK, Walczak M, Germeraad WT, Bos GM
|
27014565
|
12-01-2016
|
14-04-2026
|
|
|
The use of combinations of monoclonal antibodies in clinical oncology.
|
Henricks LM, Schellens JH, Huitema AD, Beijnen JH
|
26547132
|
01-12-2015
|
06-05-2026
|
|
|
Clinical relevance of DPYD variants c.1679T>G, c.1236G>A/HapB3, and c.1601G>A as predictors of severe fluoropyrimidine-associated toxicity: a systematic review and meta-analysis of individual patient data.
|
Meulendijks D, Henricks LM, Sonke GS, Deenen MJ, Froehlich TK, Amstutz U, Largiadèr CR, Jennings BA, Marinaki AM, Sanderson JD, Kleibl Z, Kleiblova P, Schwab M, Zanger UM, Palles C, Tomlinson I, Gross E, van Kuilenburg AB, Punt CJ, Koopman M, Beijnen JH, Cats A, Schellens JH
|
26603945
|
01-12-2015
|
06-05-2026
|
|
|
Post-Prandial Protein Handling: You Are What You Just Ate.
|
Groen BB, Horstman AM, Hamer HM, de Haan M, van Kranenburg J, Bierau J, Poeze M, Wodzig WK, Rasmussen BB, van Loon LJ
|
26556791
|
10-11-2015
|
14-04-2026
|
|
|
RasGRP1 opposes proliferative EGFR-SOS1-Ras signals and restricts intestinal epithelial cell growth.
|
Depeille P, Henricks LM, van de Ven RA, Lemmens E, Wang CY, Matli M, Werb Z, Haigis KM, Donner D, Warren R, Roose JP
|
26005835
|
01-06-2015
|
06-05-2026
|
|
|
Integrating multiple omics to unravel mechanisms of Cyclosporin A induced hepatotoxicity in vitro.
|
Van den Hof WF, Ruiz-Aracama A, Van Summeren A, Jennen DG, Gaj S, Coonen ML, Brauers K, Wodzig WK, van Delft JH, Kleinjans JC
|
25562108
|
01-04-2015
|
14-04-2026
|
|
|
Translating DPYD genotype into DPD phenotype: using the DPYD gene activity score.
|
Henricks LM, Lunenburg CA, Meulendijks D, Gelderblom H, Cats A, Swen JJ, Schellens JH, Guchelaar HJ
|
26265346
|
01-01-2015
|
06-05-2026
|
|
|
Removal of urea in a wearable dialysis device: a reappraisal of electro-oxidation.
|
Wester M, Simonis F, Lachkar N, Wodzig WK, Meuwissen FJ, Kooman JP, Boer WH, Joles JA, Gerritsen KG
|
24750025
|
01-12-2014
|
14-04-2026
|
|
|
Integrative cross-omics analysis in primary mouse hepatocytes unravels mechanisms of cyclosporin A-induced hepatotoxicity.
|
Van den Hof WF, Van Summeren A, Lommen A, Coonen ML, Brauers K, van Herwijnen M, Wodzig WK, Kleinjans JC
|
25047351
|
03-10-2014
|
14-04-2026
|
|
